{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:26:36Z","timestamp":1761488796527},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T00:00:00Z","timestamp":1320969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10549-011-1858-7","type":"journal-article","created":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T06:10:53Z","timestamp":1320905453000},"page":"915-924","source":"Crossref","is-referenced-by-count":55,"title":["A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer"],"prefix":"10.1007","volume":"131","author":[{"given":"Michaela J.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana M.","family":"Prowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L.","family":"Blackford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagi F.","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon A.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacie C.","family":"Jeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah K.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leisha A.","family":"Emens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Fetting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pendleton P.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio C.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacklyn N.","family":"Thibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Rae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Folkerd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Dowsett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy E.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vered","family":"Stearns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,11]]},"reference":[{"issue":"18","key":"1858_CR1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371\u20131388","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1858_CR2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","volume":"3","author":"VG Vogel","year":"2010","unstructured":"Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL III, Robidoux A, Margolese RG, James J, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N (2010) Update of the National Surgical Adjuvant Breast and Bowel Project Study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer. Cancer Prev Res 3(6):696\u2013706","journal-title":"Cancer Prev Res"},{"key":"1858_CR3","doi-asserted-by":"crossref","unstructured":"Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ, Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364(25):2381\u20132391","DOI":"10.1056\/NEJMoa1103507"},{"issue":"24","key":"1858_CR4","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1158\/1078-0432.CCR-04-0297","volume":"10","author":"V Stearns","year":"2004","unstructured":"Stearns V, Gallagher A, Kleer CG, Singh B, Freedman M, Haddad BR, Isaacs C, Warren R, Brown M, Cullen J, Trock B, Hayes DF (2004) A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity. Clin Cancer Res 10(24):8332\u20138340","journal-title":"Clin Cancer Res"},{"issue":"14","key":"1858_CR5","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2009.24.2495","volume":"28","author":"KE Malone","year":"2010","unstructured":"Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkjaer L, Lynch CF, Boice JD Jr, Anton-Culver H, Bernstein JL (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28(14):2404\u20132410","journal-title":"J Clin Oncol"},{"issue":"5","key":"1858_CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cct.2009.04.007","volume":"30","author":"H Penttinen","year":"2009","unstructured":"Penttinen H, Nikander R, Blomqvist C, Luoto R, Saarto T (2009) Recruitment of breast cancer survivors into a 12-month supervised exercise intervention is feasible. Contemp Clin Trials 30(5):457\u2013463","journal-title":"Contemp Clin Trials"},{"issue":"12","key":"1858_CR7","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","volume":"22","author":"MR Graaf","year":"2004","unstructured":"Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ (2004) The risk of cancer in users of statins. J Clin Oncol 22(12):2388\u20132394","journal-title":"J Clin Oncol"},{"issue":"15","key":"1858_CR8","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/archinte.160.15.2363","volume":"160","author":"L Blais","year":"2000","unstructured":"Blais L, Desgagne A, LeLorier J (2000) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 160(15):2363\u20132368","journal-title":"Arch Intern Med"},{"issue":"8","key":"1858_CR9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/154099903322447710","volume":"12","author":"JA Cauley","year":"2003","unstructured":"Cauley JA, Zmuda JM, Lui LY, Hillier TA, Ness RB, Stone KL, Cummings SR, Bauer DC (2003) Lipid-lowering drug use and breast cancer in older women: a prospective study. J Women\u2019s Health (2002) 12(8):749\u2013756","journal-title":"J Women\u2019s Health (2002)"},{"issue":"15","key":"1858_CR10","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.ejca.2008.06.025","volume":"44","author":"J Kuoppala","year":"2008","unstructured":"Kuoppala J, Lamminpaa A, Pukkala E (2008) Statins and cancer: a systematic review and meta-analysis. Eur J Cancer 44(15):2122\u20132132","journal-title":"Eur J Cancer"},{"issue":"4","key":"1858_CR11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ijc.22366","volume":"120","author":"DR Browning","year":"2007","unstructured":"Browning DR, Martin RM (2007) Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer 120(4):833\u2013843","journal-title":"Int J Cancer"},{"issue":"1","key":"1858_CR12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","volume":"295","author":"KM Dale","year":"2006","unstructured":"Dale KM, Coleman CI, Henyan NN, Kluger J, White CM (2006) Statins and cancer risk: a meta-analysis. JAMA 295(1):74\u201380","journal-title":"JAMA"},{"issue":"34","key":"1858_CR13","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1200\/JCO.2005.02.7045","volume":"23","author":"S Bonovas","year":"2005","unstructured":"Bonovas S, Filioussi K, Tsavaris N, Sitaras NM (2005) Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies. J Clin Oncol 23(34):8606\u20138612","journal-title":"J Clin Oncol"},{"issue":"5","key":"1858_CR14","first-page":"1317","volume":"21","author":"S Kang","year":"2009","unstructured":"Kang S, Kim ES, Moon A (2009) Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras. Oncol Rep 21(5):1317\u20131322","journal-title":"Oncol Rep"},{"issue":"2","key":"1858_CR15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1677\/ERC-10-0009","volume":"17","author":"C Laezza","year":"2010","unstructured":"Laezza C, Malfitano AM, Proto MC, Esposito I, Gazzerro P, Formisano P, Pisanti S, Santoro A, Caruso MG, Bifulco M (2010) Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. Endocr Relat Cancer 17(2):495\u2013503","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"1858_CR16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djj188","volume":"98","author":"JA Cauley","year":"2006","unstructured":"Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT (2006) Statin use and breast cancer: prospective results from the Women\u2019s Health Initiative. J Natl Cancer Inst 98(10):700\u2013707","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"1858_CR17","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/jnci\/djr291","volume":"103","author":"TP Ahern","year":"2011","unstructured":"Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sorensen HT, Lash TL (2011) Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst 103(19):1461\u20131468","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"1858_CR18","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","volume":"295","author":"VG Vogel","year":"2006","unstructured":"Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL III, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N (2006) Effects of tamoxifen vs. raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA 295(23):2727\u20132741","journal-title":"JAMA"},{"issue":"8","key":"1858_CR19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"T Key","year":"2002","unstructured":"Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606\u2013616","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1858_CR20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2214\/ajr.126.6.1130","volume":"126","author":"JN Wolfe","year":"1976","unstructured":"Wolfe JN (1976) Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 126(6):1130\u20131137","journal-title":"AJR Am J Roentgenol"},{"issue":"14","key":"1858_CR21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","volume":"350","author":"J Danesh","year":"2004","unstructured":"Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350(14):1387\u20131397","journal-title":"N Engl J Med"},{"issue":"21","key":"1858_CR22","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1200\/JCO.2008.18.9068","volume":"27","author":"BL Pierce","year":"2009","unstructured":"Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, Ulrich CM (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27(21):3437\u20133444","journal-title":"J Clin Oncol"},{"issue":"1","key":"1858_CR23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinchem\/43.1.52","volume":"43","author":"EM Macy","year":"1997","unstructured":"Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43(1):52\u201358","journal-title":"Clin Chem"},{"issue":"7","key":"1858_CR24","first-page":"1957","volume":"47","author":"M Dowsett","year":"1987","unstructured":"Dowsett M, Goss PE, Powles TJ, Hutchinson G, Brodie AM, Jeffcoate SL, Coombes RC (1987) Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Res 47(7):1957\u20131961","journal-title":"Cancer Res"},{"issue":"12","key":"1858_CR25","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djh167","volume":"96","author":"AM Dunning","year":"2004","unstructured":"Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA (2004) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96(12):936\u2013945","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1858_CR26","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/jc.2005-2378","volume":"91","author":"JS Lee","year":"2006","unstructured":"Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, Chandler W, Settlage J, Beattie MS, Folkerd E, Dowsett M, Grady D, Cummings SR (2006) Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 91(10):3791\u20133797","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1858_CR27","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1200\/JCO.2007.13.9279","volume":"26","author":"JM Dixon","year":"2008","unstructured":"Dixon JM, Renshaw L, Young O, Murray J, Macaskill EJ, McHugh M, Folkerd E, Cameron DA, A\u2019Hern RP, Dowsett M (2008) Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer. J Clin Oncol 26(10):1671\u20131676","journal-title":"J Clin Oncol"},{"issue":"6","key":"1858_CR28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473\u2013483","journal-title":"Med Care"},{"issue":"10","key":"1858_CR29","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1088\/0031-9155\/39\/10\/008","volume":"39","author":"JW Byng","year":"1994","unstructured":"Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39(10):1629\u20131638","journal-title":"Phys Med Biol"},{"issue":"3","key":"1858_CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/bcr2102","volume":"10","author":"MJ Yaffe","year":"2008","unstructured":"Yaffe MJ (2008) Mammographic density. Measurement of mammographic density. Breast Cancer Res 10(3):209","journal-title":"Breast Cancer Res"},{"issue":"15","key":"1858_CR31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/jnci\/djm062","volume":"99","author":"RM Tamimi","year":"2007","unstructured":"Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99(15):1178\u20131187","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1858_CR32","first-page":"625","volume":"12","author":"J Stone","year":"2003","unstructured":"Stone J, Gunasekara A, Martin LJ, Yaffe M, Minkin S, Boyd NF (2003) The detection of change in mammographic density. Cancer Epidemiol Biomark Prev 12(7):625\u2013630","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"1858_CR33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/01.fpc.0000114762.78957.a5","volume":"14","author":"KT Kivisto","year":"2004","unstructured":"Kivisto KT, Niemi M, Schaeffeler E, Pitkala K, Tilvis R, Fromm MF, Schwab M, Eichelbaum M, Strandberg T (2004) Lipid-lowering response to statins is affected by CYP3A5 polymorphism. Pharmacogenetics 14(8):523\u2013525","journal-title":"Pharmacogenetics"},{"issue":"5","key":"1858_CR34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1158\/1940-6207.CAPR-10-0007","volume":"3","author":"SM Lipkin","year":"2010","unstructured":"Lipkin SM, Chao EC, Moreno V, Rozek LS, Rennert H, Pinchev M, Dizon D, Rennert G, Kopelovich L, Gruber SB (2010) Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer. Cancer Prev Res (Phila) 3(5):597\u2013603","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"1858_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11584380-000000000-00000","volume":"34","author":"SD Maggo","year":"2011","unstructured":"Maggo SD, Kennedy MA, Clark DW (2011) Clinical implications of pharmacogenetic variation on the effects of statins. Drug Saf 34(1):1\u201319","journal-title":"Drug Saf"},{"issue":"29","key":"1858_CR36","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1200\/JCO.2010.31.0102","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes MD (2010) Challenge of balancing alcohol intake. J Clin Oncol 28(29):4403\u20134404","journal-title":"J Clin Oncol"},{"issue":"12","key":"1858_CR37","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1210\/jc.2003-031279","volume":"88","author":"N Mauras","year":"2003","unstructured":"Mauras N, Lima J, Patel D, Rini A, di Salle E, Kwok A, Lippe B (2003) Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males. J Clin Endocrinol Metab 88(12):5951\u20135956","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1858_CR38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/(SICI)1099-081X(199712)18:9<779::AID-BDD64>3.0.CO;2-5","volume":"18","author":"A Sioufi","year":"1997","unstructured":"Sioufi A, Gauducheau N, Pineau V, Marfil F, Jaouen A, Cardot JM, Godbillon J, Czendlik C, Howald H, Pfister C, Vreeland F (1997) Absolute bioavailability of letrozole in healthy postmenopausal women. Biopharm Drug Dispos 18(9):779\u2013789","journal-title":"Biopharm Drug Dispos"},{"issue":"9","key":"1858_CR39","first-page":"967","volume":"10","author":"A Guerrieri-Gonzaga","year":"2001","unstructured":"Guerrieri-Gonzaga A, Baglietto L, Johansson H, Bonanni B, Robertson C, Sandri MT, Canigiula L, Lampreda C, Diani S, Lien EA, Decensi A (2001) Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial. Cancer Epidemiol Biomark Prev 10(9):967\u2013970","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"1858_CR40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.20.3.751","volume":"20","author":"J Geisler","year":"2002","unstructured":"Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE (2002) Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 20(3):751\u2013757","journal-title":"J Clin Oncol"},{"issue":"3\u20135","key":"1858_CR41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0960-0760(03)00364-9","volume":"86","author":"J Geisler","year":"2003","unstructured":"Geisler J (2003) Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators. J Steroid Biochem Mol Biol 86(3\u20135):245\u2013253","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"1858_CR42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1677\/joe.0.1530307","volume":"153","author":"J Geisler","year":"1997","unstructured":"Geisler J, Engelsen BA, Berntsen H, Geisler S, Lonning PE (1997) Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients. J Endocrinol 153(2):307\u2013312","journal-title":"J Endocrinol"},{"issue":"1\u20133","key":"1858_CR43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0960-0760(97)00071-X","volume":"63","author":"J Geisler","year":"1997","unstructured":"Geisler J, Lien EA, Ekse D, Lonning PE (1997) Influence of aminoglutethimide on plasma levels of estrone sulphate and dehydroepiandrosterone sulphate in postmenopausal breast cancer patients. J Steroid Biochem Mol Biol 63(1\u20133):53\u201358","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"1858_CR44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jnci\/djh106","volume":"96","author":"J Cuzick","year":"2004","unstructured":"Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96(8):621\u2013628","journal-title":"J Natl Cancer Inst"},{"issue":"36","key":"1858_CR45","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1200\/JCO.2008.21.7166","volume":"27","author":"A McTiernan","year":"2009","unstructured":"McTiernan A, Chlebowski RT, Martin C, Peck JD, Aragaki A, Pisano ED, Wang CY, Johnson KC, Manson JE, Wallace RB, Vitolins MZ, Heiss G (2009) Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women\u2019s health initiative randomized trial. J Clin Oncol 27(36):6135\u20136143.6","journal-title":"J Clin Oncol"},{"key":"1858_CR46","doi-asserted-by":"crossref","unstructured":"Bardia A, Stearns V (2010) Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy. Breast Cancer Res Treat 120(2):437\u2013439. doi: 10.1007\/s10549-010-0787-1","DOI":"10.1007\/s10549-010-0787-1"},{"issue":"1","key":"1858_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10549-006-9476-5","volume":"106","author":"CJ Fabian","year":"2007","unstructured":"Fabian CJ, Kimler BF, Zalles CM, Khan QJ, Mayo MS, Phillips TA, Simonsen M, Metheny T, Petroff BK (2007) Reduction in proliferation with six months of letrozole in women on hormone replacement therapy. Breast Cancer Res Treat 106(1):75\u201384","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"1858_CR48","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1200\/JCO.2005.07.559","volume":"23","author":"M Dowsett","year":"2005","unstructured":"Dowsett M, Ebbs SR, Dixon JM, Skene A, Griffith C, Boeddinghaus I, Salter J, Detre S, Hills M, Ashley S, Francis S, Walsh G, Smith IE (2005) Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer\u2014a study from the IMPACT trialists. J Clin Oncol 23(11):2477\u20132492","journal-title":"J Clin Oncol"},{"issue":"28","key":"1858_CR49","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1200\/JCO.2005.07.501","volume":"23","author":"A Urruticoechea","year":"2005","unstructured":"Urruticoechea A, Smith IE, Dowsett M (2005) Proliferation marker Ki-67 in early breast cancer. J Clin Oncol 23(28):7212\u20137220","journal-title":"J Clin Oncol"},{"issue":"7","key":"1858_CR50","first-page":"614","volume":"11","author":"C Harper-Wynne","year":"2002","unstructured":"Harper-Wynne C, Ross G, Sacks N, Salter J, Nasiri N, Iqbal J, A\u2019Hern R, Dowsett M (2002) Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention. Cancer Epidemiol Biomark Prev 11(7):614\u2013621","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"23","key":"1858_CR51","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2008.19.3797","volume":"27","author":"A Decensi","year":"2009","unstructured":"Decensi A, Robertson C, Guerrieri-Gonzaga A, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Galimberti V, Cassano E, Moroni SM, Formelli F, Lien EA, Pelosi G, Johnson KA, Bonanni B (2009) Randomized double-blind 2\u00a0\u00d7\u00a02 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. J Clin Oncol 27(23):3749\u20133756","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1858-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1858-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T09:45:13Z","timestamp":1593251113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1858-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,11]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1858"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1858-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,11]]}}}